Summary
This narrative review examines the role of broad-spectrum micronutrient formulations in addressing emotional dysregulation across a range of psychiatric conditions. The authors argue that whilst adequate nutritional intake is essential for mental health, modern dietary patterns and agricultural practices often result in micronutrient insufficiency, and that targeted BSM supplementation may therefore represent a complementary intervention alongside dietary improvement. Evidence from research on three BSM formulations is presented as demonstrating positive outcomes for emotional regulation in ADHD, autism, trauma, mood disorders, nicotine dependence, and psychosis.
UK applicability
The findings are potentially applicable to UK mental health practice and policy, particularly given widespread consumption of ultra-processed foods and recognised nutritional inadequacy in portions of the population. However, the review does not specify UK-specific prevalence data, farming practices, or regulatory pathways for micronutrient supplementation in psychiatric care, limiting direct policy implications.
Key measures
Emotional regulation outcomes; clinical efficacy across psychiatric diagnoses (ADHD, autism, trauma, mood disorders, nicotine dependence, psychosis)
Outcomes reported
The study reviewed evidence on broad-spectrum micronutrient (BSM) formulations and their efficacy in treating emotional dysregulation across multiple psychiatric conditions including ADHD, autism, trauma, mood disorders, nicotine dependence, and psychosis. Outcomes measured included emotional regulation markers and clinical improvements in these psychiatric illnesses.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.